Literature DB >> 11429444

In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.

T C Rich1, T E Tse, J G Rohan, J Schaack, J W Karpen.   

Abstract

Phosphodiesterases (PDEs) catalyze the hydrolysis of the second messengers cAMP and cGMP. However, little is known about how PDE activity regulates cyclic nucleotide signals in vivo because, outside of specialized cells, there are few methods with the appropriate spatial and temporal resolution to measure cyclic nucleotide concentrations. We have previously demonstrated that adenovirus-expressed, olfactory cyclic nucleotide-gated channels provide real-time sensors for cAMP produced in subcellular compartments of restricted diffusion near the plasma membrane (Rich, T.C., K.A. Fagan, H. Nakata, J. Schaack, D.M.F. Cooper, and J.W. Karpen. 2000. J. Gen. Physiol. 116:147-161). To increase the utility of this method, we have modified the channel, increasing both its cAMP sensitivity and specificity, as well as removing regulation by Ca(2)+-calmodulin. We verified the increased sensitivity of these constructs in excised membrane patches, and in vivo by monitoring cAMP-induced Ca(2)+ influx through the channels in cell populations. The improved cAMP sensors were used to monitor changes in local cAMP concentration induced by adenylyl cyclase activators in the presence and absence of PDE inhibitors. This approach allowed us to identify localized PDE types in both nonexcitable HEK-293 and excitable GH4C1 cells. We have also developed a quantitative framework for estimating the K(I) of PDE inhibitors in vivo. The results indicate that PDE type IV regulates local cAMP levels in HEK-293 cells. In GH4C1 cells, inhibitors specific to PDE types I and IV increased local cAMP levels. The results suggest that in these cells PDE type IV has a high K(m) for cAMP, whereas PDE type I has a low K(m) for cAMP. Furthermore, in GH4C1 cells, basal adenylyl cyclase activity was readily observable after application of PDE type I inhibitors, indicating that there is a constant synthesis and hydrolysis of cAMP in subcellular compartments near the plasma membrane. Modulation of constitutively active adenylyl cyclase and PDE would allow for rapid control of cAMP-regulated processes such as cellular excitability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429444      PMCID: PMC2233745          DOI: 10.1085/jgp.118.1.63

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  77 in total

1.  Adenovirus-mediated expression of an olfactory cyclic nucleotide-gated channel regulates the endogenous Ca2+-inhibitable adenylyl cyclase in C6-2B glioma cells.

Authors:  K A Fagan; T C Rich; S Tolman; J Schaack; J W Karpen; D M Cooper
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

2.  Enzymatic hydrolysis of adenosine 3',5'-phosphoric acid.

Authors:  G I DRUMMOND; S PERROTT-YEE
Journal:  J Biol Chem       Date:  1961-04       Impact factor: 5.157

3.  Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases.

Authors:  S H Soderling; S J Bayuga; J A Beavo
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

Review 4.  Photoreceptor membrane proteins, phototransduction, and retinal degenerative diseases. The Friedenwald Lecture.

Authors:  R S Molday
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

5.  Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition.

Authors:  I McPhee; S J Yarwood; G Scotland; E Huston; M B Beard; A H Ross; E S Houslay; M D Houslay
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

6.  Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.

Authors:  S H Soderling; S J Bayuga; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

7.  The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.

Authors:  R Hoffmann; G S Baillie; S J MacKenzie; S J Yarwood; M D Houslay
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

8.  Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase.

Authors:  K Loughney; T R Hill; V A Florio; L Uher; G J Rosman; S L Wolda; B A Jones; M L Howard; L M McAllister-Lucas; W K Sonnenburg; S H Francis; J D Corbin; J A Beavo; K Ferguson
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

9.  Role for the target enzyme in deactivation of photoreceptor G protein in vivo.

Authors:  S H Tsang; M E Burns; P D Calvert; P Gouras; D A Baylor; S P Goff; V Y Arshavsky
Journal:  Science       Date:  1998-10-02       Impact factor: 47.728

10.  Movement of gating machinery during the activation of rod cyclic nucleotide-gated channels.

Authors:  R L Brown; S D Snow; T L Haley
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

View more
  62 in total

Review 1.  The many dimensions of cAMP signaling.

Authors:  J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell.

Authors:  T C Rich; K A Fagan; T E Tse; J Schaack; D M Cooper; J W Karpen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  A-kinase anchoring proteins regulate compartmentalized cAMP signaling in airway smooth muscle.

Authors:  Sarah J Horvat; Deepak A Deshpande; Huandong Yan; Reynold A Panettieri; Juan Codina; Thomas D DuBose; Wenkuan Xin; Thomas C Rich; Raymond B Penn
Journal:  FASEB J       Date:  2012-05-30       Impact factor: 5.191

4.  Light modulation of cellular cAMP by a small bacterial photoactivated adenylyl cyclase, bPAC, of the soil bacterium Beggiatoa.

Authors:  Manuela Stierl; Patrick Stumpf; Daniel Udwari; Ronnie Gueta; Rolf Hagedorn; Aba Losi; Wolfgang Gärtner; Linda Petereit; Marina Efetova; Martin Schwarzel; Thomas G Oertner; Georg Nagel; Peter Hegemann
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

Review 5.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 6.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

Review 7.  A-kinase anchoring proteins take shape.

Authors:  Darren L Beene; John D Scott
Journal:  Curr Opin Cell Biol       Date:  2007-02-20       Impact factor: 8.382

8.  A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes.

Authors:  Francesca Rochais; Aniella Abi-Gerges; Kathleen Horner; Florence Lefebvre; Dermot M F Cooper; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

9.  Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells.

Authors:  Antoine Younes; Alexey E Lyashkov; David Graham; Anna Sheydina; Maria V Volkova; Megan Mitsak; Tatiana M Vinogradova; Yevgeniya O Lukyanenko; Yue Li; Abdul M Ruknudin; Kenneth R Boheler; Jennifer van Eyk; Edward G Lakatta
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

10.  Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.

Authors:  Liliana R V Castro; Ignacio Verde; Dermot M F Cooper; Rodolphe Fischmeister
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.